{"url":"https://lda.senate.gov/api/v1/filings/d071c1e1-e98a-4ccf-b755-e262770d24c5/","filing_uuid":"d071c1e1-e98a-4ccf-b755-e262770d24c5","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2014,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/d071c1e1-e98a-4ccf-b755-e262770d24c5/print/","filing_document_content_type":"text/html","income":"5000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"CHRISTOPHER KOPPEN","dt_posted":"2014-11-13T17:26:07.103000-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2003 Paul Spring Road","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Alexandria","registrant_state":"VA","registrant_zip":"22307","registrant":{"id":293610,"url":"https://lda.senate.gov/api/v1/registrants/293610/","house_registrant_id":37381,"name":"AVANCER HEALTH POLICY","description":"Government Relations, Consulting","address_1":"2003 Paul Spring Road","address_2":null,"address_3":null,"address_4":null,"city":"Alexandria","state":"VA","state_display":"Virginia","zip":"22307","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CHRISTOPHER KOPPEN","contact_telephone":"+1 571-723-7296","dt_updated":"2022-04-06T16:06:22.967373-04:00"},"client":{"id":178655,"url":"https://lda.senate.gov/api/v1/clients/178655/","client_id":125,"name":"ACURA PHARMACEUTICALS, INC.","general_description":"Pharmaceuticals","client_government_entity":false,"client_self_select":null,"state":"IL","state_display":"Illinois","country":"US","country_display":"United States of America","ppb_state":"IL","ppb_state_display":"Illinois","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2014-09-03"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Raising awareness with respect to the FDA's policy regarding the development of abuse-deterrent pharmaceuticals","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":49587,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"KOPPEN","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant, Office of Congressman Charlie Norwood","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}